News Release: Hemedex, Inc., Announces Distribution Agreement with Suporte Hospitalar Partmed Brazil

Posted by on Aug 5, 2013 in News Releases

News Release: Hemedex, Inc., Announces Distribution Agreement with Suporte Hospitalar Partmed Brazil

CAMBRIDGE, Mass. (August 5, 2013) – Hemedex, Inc., a medical device company, is pleased to announce a partnership with Suporte Hospitalar Partmed, Brazil.

Under the agreement, Partmed will be the sole distributor of Hemedex’s product line following clearance with the Brazilian regulatory body (ANVISA), expected in 2015.  Hemedex currently distributes in several countries and offers a complete solution for monitoring blood flow in patients at the bedside, including, the Bowman Perfusion Monitor® (BPM), and its accessories, the QFlow 500™ Perfusion Probe, and QFlow 500™ Titanium Bolt Kits.

“Hemedex is pleased to partner with Partmed, “ said H. Frederick Bowman, Ph.D., CEO and Chairman, Hemedex, Inc. “They have established a broad distribution network within Brazil and have successfully helped grow the adoption of other state-of-the art technologies in our market space. They are well suited to help us achieve our mission to enhance the quality of care and to improve patient outcomes.”

Suporte Hospitalar Partmed is a leader in distributing products in the fields of cardiac, spinal and neurological care. Started in 1986, Partmed has increased access to healthcare technology by introducing industrial leaders such as Boston Scientific, Datascope, Daig, Elliquence, Myelotec and others to the Brazilian market.

The Brazilian medical devices market is the largest in Latin America and is anticipated to grow from $4.7 billion in 2011 to $8.4 billion in 20151, while their clinical diagnostics market is expected to grow from $616 million in 2011 to over $950 million by 20151.

Brazil
Photo: from left to right: Scott D. Greenwald, Ph.D., Vice President of Technology, Hemedex, Inc., H. Frederick Bowman, Ph.D., President, CEO & Chairman, Hemedex, Inc., Mariana Lins, International Manager, Suporte Hospitalar, Partmed and Mathias Ostergren, Product Specialist, Suporte Hospitalar, Partmed

About Hemedex, Inc.:

Hemedex, Inc. manufactures patient monitoring technology, the Bowman Perfusion Monitor®, for quantifying tissue blood flow. The Company’s patented technology provides clinicians with a powerful tool, which can provide an early warning of compromised blood flow and help target appropriate therapies rapidly and accurately. Data from the Bowman Perfusion Monitor helps guide physicians in implementing effective treatments quickly, creating the potential to improve patient outcomes and lower costs. Hemedex’s technology addresses unmet needs in many clinical areas such as neurocritical care (e.g., TBI, SAH), neurosurgery (e.g., TAO, EC-IC Bypass, Moya Moya), reconstructive surgery and organ transplantation, among others.  For more information, visit www.hemedex.com.

 

Communications Team
Hemedex Inc.
sblair@hemedex.com
617 577 1759 X 46

 


1 Allada, Swathi, Fujioka, Willian. Healthcare Growth Opportunities in Brazil. Frost & Sullivan, 16 Aug 2012